Evidence map›Paper›PMID 42303986›Full record

ArticleNature communications2026

EasySCP unveils extensive liver zonation at single-cell proteomics resolution.

Bingbing Hao, Jinghui Wei, Jiaen Xu, Ying Fu, Qiaoyu Zou, Xu Wang, Siyu Wang, Yixuan Shi, Yale Chen, Ken Xie and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bingbing Hao *State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China. bbhao@zzu.edu.cn.ORCID http://orcid.org/0009-0006-8860-5582
Jinghui Wei *State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.
Jiaen XuState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.
Ying FuPeking University Institute of Advanced Agricultural Sciences, Shandong Laboratory of Advanced Agricultural Sciences at Weifang, Weifang, Shandong, China.
Qiaoyu ZouSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Xu WangSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Siyu WangSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
Yixuan ShiSchool of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Yale ChenSchool of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou, Henan, China.
Ken XieDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-5775-3095
Xun HuangState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.ORCID http://orcid.org/0000-0002-2653-8293
Tong-Jin ZhaoState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.ORCID http://orcid.org/0000-0001-6861-3071
Zigang DongState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.ORCID http://orcid.org/0000-0002-4174-4028
Peng LiState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China.
Guochen QinPeking University Institute of Advanced Agricultural Sciences, Shandong Laboratory of Advanced Agricultural Sciences at Weifang, Weifang, Shandong, China. guochen.qin@pku-iaas.edu.cn.ORCID http://orcid.org/0000-0002-2048-8571
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.ORCID http://orcid.org/0000-0003-2968-877X
Baoguo LiState Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China. lbg@zzu.edu.cn.ORCID http://orcid.org/0000-0001-9276-7943

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32401230
6 · The paper itself

Abstract

The broader application of single-cell proteomics (SCP) in biology has been limited by complex workflows and reliance on specialized instrumentation. Here we present EasySCP, a high-throughput method that integrates FACS-based single-cell sorting, an all-in-one, single-step digestion process in 384-well plates, and sensitive mass spectrometry. EasySCP identifies nearly 5000 proteins from individual HEK293 cell. Applied to female murine liver, EasySCP achieves spatially informed proteomics profiling of hepatocytes zonation, detecting an average of 3500 proteins per hepatocyte and uncovering zonation patterns for 3277 out of 5267 proteins. Building on 215 conserved zonation markers, we further develop hepatocyte spatial status score (HSS) that enables reconstruct liver zonation across single-cell and multi-omics datasets. Together, our study introduces EasySCP, a broadly accessible tool for dissecting cellular heterogeneity at single-cell proteomics resolution in both healthy and disease states, effectively bridging the gap between transcriptomics and functional proteomics.

Indexed as

HepatocytesLiverProteomicsSingle-Cell AnalysisAnimalsFemaleFlow CytometryHEK293 CellsHumansMass SpectrometryMiceProteomeProteome

Identifiers

PMID42303986
PMCPMC13429657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.